NYSE:NMR - New York Stock Exchange, Inc. - US65535H2085 - ADR - Currency: USD
NMR gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 233 industry peers in the Capital Markets industry. Both the profitability and financial health of NMR have multiple concerns. NMR has a decent growth rate and is not valued too expensively.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 0.6% | ||
ROE | 9.82% | ||
ROIC | 0.62% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 9.96% | ||
PM (TTM) | 7.19% | ||
GM | 39.95% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 10.44 | ||
Debt/FCF | N/A | ||
Altman-Z | -0.25 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 0.23 | ||
Quick Ratio | 0.23 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 7.75 | ||
Fwd PE | 8.11 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | 21.87 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 5.07% |
6.28
-0.23 (-3.53%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 5.07% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 7.75 | ||
Fwd PE | 8.11 | ||
P/S | 0.57 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 0.78 | ||
P/tB | 0.78 | ||
EV/EBITDA | 21.87 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 0.6% | ||
ROE | 9.82% | ||
ROCE | 1.58% | ||
ROIC | 0.62% | ||
ROICexc | 0.68% | ||
ROICexgc | 0.69% | ||
OM | 9.96% | ||
PM (TTM) | 7.19% | ||
GM | 39.95% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 10.44 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | 67.92 | ||
Cap/Depr | 1410.99% | ||
Cap/Sales | 18.37% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 0.23 | ||
Quick Ratio | 0.23 | ||
Altman-Z | -0.25 |